Publicación:
In Silico Study of Coumarins and Quinolines Derivatives as Potent Inhibitors of SARS-CoV-2 Main Protease

Vista sencilla de ítem
dc.contributor.authorYañez, Osvaldo
dc.contributor.authorOsorio, Manuel Isaías
dc.contributor.authorUriarte, Eugenio
dc.contributor.authorAreche, Carlos
dc.contributor.authorTiznado, William
dc.contributor.authorPérez-Donoso, José M.
dc.contributor.authorGarcía-Beltrán, Olimpo
dc.contributor.authorGonzález-Nilo, Fernando
dc.date.accessioned2021-07-23T20:55:07Z
dc.date.available2021-07-23T20:55:07Z
dc.date.issued2021-02-08
dc.description.abstractThe pandemic that started in Wuhan (China) in 2019 has caused a large number of deaths, and infected people around the world due to the absence of effective therapy against coronavirus 2 of the severe acute respiratory syndrome (SARS-CoV-2). Viral maturation requires the activity of the main viral protease (Mpro), so its inhibition stops the progress of the disease. To evaluate possible inhibitors, a computational model of the SARS-CoV-2 enzyme Mpro was constructed in complex with 26 synthetic ligands derived from coumarins and quinolines. Analysis of simulations of molecular dynamics and molecular docking of the models show a high affinity for the enzyme (∆Ebinding between −5.1 and 7.1 kcal mol−1). The six compounds with the highest affinity show Kd between 6.26 × 10–6 and 17.2 × 10–6, with binding affinity between −20 and −25 kcal mol−1, with ligand efficiency less than 0.3 associated with possible inhibitory candidates. In addition to the high affinity of these compounds for SARS-CoV-2 Mpro, low toxicity is expected considering the Lipinski, Veber and Pfizer rules. Therefore, this novel study provides candidate inhibitors that would allow experimental studies which can lead to the development of new treatments for SARS-CoV-2.es_CO
dc.description.sponsorshipUniversidad de Ibaguées_CO
dc.identifier.citationYañez O, Osorio MI, Uriarte E, Areche C, Tiznado W, Perez-donoso JM, García O and González FD(2020) In Silico Study of Coumarins and Quinolines Derivatives as Potent Inhibitors of SARS-CoV-2 Main Protease. Front. Chem. 8:1273. doi:10.3389/fchem.2020.595097es_CO
dc.identifier.issn2296-2646
dc.identifier.urihttps://www.frontiersin.org/articles/10.3389/fchem.2020.595097/full
dc.language.isoenes_CO
dc.publisherFrontiers in Chemistryes_CO
dc.subjectCoumarinses_CO
dc.subjectMolecular dynamicses_CO
dc.subjectProteasees_CO
dc.subjectQuinolineses_CO
dc.subjectSARS-CoV-2es_CO
dc.titleIn Silico Study of Coumarins and Quinolines Derivatives as Potent Inhibitors of SARS-CoV-2 Main Proteasees_CO
dc.typeArticlees_CO
dspace.entity.typePublication
eperson.emailjose.garcia@unibague.edu.coes_CO
Archivos
Bloque de licencias
Mostrando1 - 1 de 1
Miniatura
Nombre:
license.txt
Tamaño:
134 B
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
Colecciones
Artículos